TOX3 is expressed in mammary ER+ epithelial cells and regulates ER target genes in luminal breast cancer

被引：0
|
作者：
Akop Seksenyan
Asha Kadavallore
Ann E Walts
Brian de la Torre
Dror Berel
Samuel P Strom
Parinaz Aliahmad
Vincent A Funari
Jonathan Kaye
机构：
[1] Cedars-Sinai Medical Center,Research Division of Immunology, Departments of Biomedical Sciences and Medicine
[2] Cedars-Sinai Medical Center,Department of Pathology and Laboratory Medicine
[3] Samuel Oschin Comprehensive Cancer Institute,Center for Applied Molecular Medicine
[4] Cedars-Sinai Medical Center,Genomics Core Facility
[5] University of Southern California,Department of Pathology and Laboratory Medicine
[6] Keck School of Medicine,Department of Medicine, David Geffen School of Medicine
[7] Cedars-Sinai Medical Center,undefined
[8] University of California Los Angeles David Geffen School of Medicine,undefined
[9] University of California,undefined
来源：
BMC Cancer | / 15卷
关键词：
TOX3; Luminal B breast cancer; TFF1; HMG-box factor; ER target gene activation; Mammary epithelial progenitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] ERE-independent ERα target genes differentially expressed in human breast tumors
    Glidewell-Kenney, C
    Weiss, J
    Lee, EJ
    Pillai, S
    Ishikawa, T
    Ariazi, EA
    Jameson, JL
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2005, 245 (1-2) : 53 - 59
  • [22] Epithelial estrogen receptor a (ERα) regulates the proliferation of prostate cancer cells
    Takizawa, Itsuhiro
    Lawrence, Mitchell
    Pearson, Helen
    Pouliot, Normand
    Pedersen, John
    Humbert, Patrick
    Furic, Luc
    Risbridger, Gail
    BJU INTERNATIONAL, 2013, 112 : 37 - 37
  • [23] In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells
    De Amicis, Francesca
    Russo, Alessandra
    Avena, Paola
    Santoro, Marta
    Vivacqua, Adele
    Bonofiglio, Daniela
    Mauro, Loredana
    Aquila, Saveria
    Tramontano, Donatella
    Fuqua, Suzanne A. W.
    Ando, Sebastiano
    MOLECULAR NUTRITION & FOOD RESEARCH, 2013, 57 (05) : 840 - 853
  • [24] Differentially Expressed Proteins in ER+ MCF7 and ER- MDA-MB-231 Human Breast Cancer Cells by RhoGDI-α Silencing and Overexpression
    Hooshmand, Somayeh
    Ghaderi, Abbas
    Yusoff, Khatijah
    Thilakavathy, Karuppiah
    Rosli, Rozita
    Mojtahedi, Zahra
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (07) : 3311 - 3317
  • [25] PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells
    Miranda E. Clements
    Rachelle W. Johnson
    Oncogene, 2020, 39 : 1318 - 1334
  • [26] TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells
    Scott, Thomas G.
    Sathyan, Kizhakke Mattada
    Gioeli, Daniel
    Guertin, Michael J.
    PLOS GENETICS, 2024, 20 (02):
  • [27] RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells
    van Bragt, Maaike P. A.
    Hu, Xin
    Xie, Ying
    Li, Zhe
    ELIFE, 2014, 3 : 1 - 23
  • [28] Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer
    Servetto, Alberto
    Kollipara, Rahul
    Formisano, Luigi
    Lin, Chang-Ching
    Lee, Kyung-Min
    Sudhan, Dhivya R.
    Gonzalez-Ericsson, Paula I.
    Chatterjee, Sumanta
    Guerrero-Zotano, Angel
    Mendiratta, Saurabh
    Akamatsu, Hiroaki
    James, Nicholas
    Bianco, Roberto
    Hanker, Ariella B.
    Kittler, Ralf
    Arteaga, Carlos L.
    CLINICAL CANCER RESEARCH, 2021, 27 (15) : 4379 - 4396
  • [29] Comprehensive clinical and molecular portraits of grade 3 ER+ HER-breast cancer
    Wang, K.
    Franch-Exposito, S.
    Li, L.
    Xiang, T.
    Wu, J.
    Ren, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S27 - S27
  • [30] TRIM29 Functions as a Tumor Suppressor in Nontumorigenic Breast Cells and Invasive ER+ Breast Cancer
    Liu, Jin
    Welm, Bryan
    Boucher, Ken M.
    Ebbert, Mark T. W.
    Bernard, Philip S.
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 180 (02): : 839 - 847
12345